Two More National Hospitals Groups Urge CMS to Stop 340B Drug Cost Survey

Two more national hospital groups have asked the Centers for Medicare & Medicaid Services (CMS) to stop surveying 340B hospitals about their costs to acquire drugs that they bill to Medicare Part B.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content

Sign up for news summaries and alerts from 340B Report